Retroviral replicating vector-mediated suicide gene therapy for osteosarcoma

被引：0
|
作者：
Kubo, Shuji [1 ]
Takagi-Kimura, Misato [1 ]
Yamano, Tomoki [2 ]
Kasahara, Noriyuki [3 ]
机构：
[1] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo, Japan
[2] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan
[3] Univ Miami, Dept Cell Biol & Path, Coral Gables, FL 33124 USA
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Oncolytic virus; Osteosarcoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3051
引用
收藏
页码：961 / 961
页数：1
相关论文
共 50 条
  • [1] Retroviral replicating vector-mediated prodrug activator gene therapy in an experimental model of human osteosarcoma
    Kubo, S.
    Takagi-Kimura, M.
    Kasahara, N.
    HUMAN GENE THERAPY, 2017, 28 (12) : A28 - A29
  • [2] Retroviral Replicating Vector-Mediated Prodrug-Activator Gene Therapy for Canine Cancers
    Sonoda, Emiko
    Noguchi, Shunsuke
    Kasahara, Noriyuki
    Kubo, Shuji
    MOLECULAR THERAPY, 2023, 31 (04) : 477 - 477
  • [3] Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer
    Inoko, Kazuho
    Hiraoka, Kei
    Inagaki, Akihito
    Takahashi, Mizuna
    Kushibiki, Toshihiro
    Hontani, Koji
    Takano, Hironobu
    Sato, Shoki
    Takeuchi, Shintaro
    Nakamura, Toru
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Gruber, Harry E.
    Jolly, Douglas J.
    Kasahara, Noriyuki
    Hirano, Satoshi
    CANCER GENE THERAPY, 2018, 25 (7-8) : 184 - 195
  • [4] Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer
    Kazuho Inoko
    Kei Hiraoka
    Akihito Inagaki
    Mizuna Takahashi
    Toshihiro Kushibiki
    Koji Hontani
    Hironobu Takano
    Shoki Sato
    Shintaro Takeuchi
    Toru Nakamura
    Takahiro Tsuchikawa
    Toshiaki Shichinohe
    Harry E Gruber
    Douglas J Jolly
    Noriyuki Kasahara
    Satoshi Hirano
    Cancer Gene Therapy, 2018, 25 : 184 - 195
  • [5] Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy
    Lee, YJ
    Galoforo, SS
    Battle, P
    Lee, H
    Corry, PM
    Jessup, JM
    CANCER GENE THERAPY, 2001, 8 (06) : 397 - 404
  • [6] Potential Utility of Retroviral Replicating Vector-Mediated Prodrug Activator Gene Therapy for Human Ovarian Cancer
    Kubo, Shuji
    Isoda, Lisa
    Fujino, Hiroaki
    Sonoda, Emiko
    Hasegawa, Kosei
    Kasahara, Noriyuki
    Takarada, Toru
    MOLECULAR THERAPY, 2020, 28 (04) : 345 - 345
  • [7] INHIBITION OF EXPERIMENTAL PVR BY RETROVIRAL VECTOR-MEDIATED TRANSFER OF SUICIDE GENE
    SAKAMOTO, T
    KIMURA, H
    SPEE, C
    HINTON, DR
    SCURIC, Z
    GORDON, EM
    ANDERSON, WF
    RYAN, SJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S748 - S748
  • [8] Retroviral Vector-mediated Gene Therapy for Metabolic Diseases: An Update
    Ferry, Nicolas
    Pichard, Virginie
    Bony, Dominique Aubert Sebastien
    Tuan Huy Nguyen
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (24) : 2516 - 2527
  • [9] Usefulness of suicide gene therapy for ovarian cancer using retroviral replicating vector
    Kubo, Shuji
    Yamano, Tomoki
    Hasegawa, Kosei
    CANCER SCIENCE, 2021, 112 : 583 - 583
  • [10] Retroviral Replicating Vector-Mediated Prodrug Activator Gene Therapy with Engineered Human Mesenchymal Stem Cells in an Experimental Glioma Model
    Inagaki, Akihito
    Takahashi, Masamichi
    Kamijima, Shuichi
    Hiraoka, Kei
    Quincy Tam
    Faure-Kumar, Emmanuelle
    Treger, Janet
    Bogan, Brooke
    Hacke, Katrin
    Collins, Sara
    Jolly, Douglas
    Kasahara, Noriyuki
    MOLECULAR THERAPY, 2019, 27 (04) : 208 - 209
12345